PharmTech

JULY 17, 2025

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

52

52

pharmaphorum

JULY 17, 2025

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

66

66

Pharma Times

JULY 17, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Seaport Therapeutics begins phase 2b trial of GlyphAllo for major depression by John Pinching | 17th Jul 2025 | News First patient dosed in BUOY-1 study targeting MDD with or without anxious distress Seaport Therapeutics has dosed the first patient in its phase 2b BUOY-1 trial of GlyphAllo, a novel oral prodr

26

26

pharmaphorum

JULY 17, 2025

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers can now transform their strategies by using models to duplicate biological systems.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharma Times

JULY 17, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership One Biosciences raises €15 million to advance single-cell oncology platform by John Pinching | 17th Jul 2025 | News Funding to accelerate development of AI-driven tumour profiling tool OneMap One Biosciences has secured €15 million in Series A financing to expand its AI-powered single-cell transcriptomic plat

26

26

pharmaphorum

JULY 17, 2025

Novartis' breast cancer therapy Kisqali has been cleared for NHS use in early breast cancer, an indication driving blockbuster sales of the drug

52

52

pharmaphorum

JULY 17, 2025

As public funding becomes more uncertain, lab and clinical services professionals are increasingly being called on to help pharma, biotech, and diagnostics companies maintain, and accelerate, momentum.

52

52

pharmaphorum

JULY 17, 2025

OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research

52

52

pharmaphorum

JULY 17, 2025

The UK has unveiled its plan to revitalise the life sciences sector and become a global leader by 2030, but a pharma group says it falls short.

82

82

pharmaphorum

JULY 17, 2025

Johnson & Johnson presented over 70 abstracts at ASCO 2025, showcasing a bold oncology vision. Mark Wildgust discusses their global ambition to redefine cancer care—watch the full conversation!

52

52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

JULY 17, 2025

AIs that detect spinal fractures during routine CT scans could help the NHS reduce hip fractures and other costly complications, says NICE.

59

59

pharmaphorum

JULY 17, 2025

Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround for the group starts to deliver results.

40

40

pharmaphorum

JULY 17, 2025

Skip to main content Thursday 17 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -W

Immunization 52

Immunization Pharmaceutical Companies Pharmaceutical Companies 52